1. AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma. (1st February 2018) Authors: Wang, Li-Li; Jin, Xiao-Han; Cai, Mu-Yan; Li, Hai-Gang; Chen, Jie-Wei; Wang, Feng-Wei; Wang, Chen-Yuan; Hu, Wei-Wei; Liu, Fang; Xie, Dan Journal: Cancer letters Issue: Volume 414(2018) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma. (31st March 2016) Authors: Li, Chang-Peng; Cai, Mu-Yan; Jiang, Li-Juan; Mai, Shi-Juan; Chen, Jie-Wei; Wang, Feng-Wei; Liao, Yi-Ji; Chen, Wen-Hui; Jin, Xiao-Han; Pei, Xiao-Qing; Guan, Xin-Yuan; Zeng, Mu-Sheng; Xie, Dan Journal: Carcinogenesis Issue: Volume 37:Number 6(2016:Jun.) Page Start: 557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Corrigendum to "AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma" [Canc. Lett. 414 (2018) 71–80]. (28th July 2022) Authors: Wang, Li-Li; Jin, Xiao-Han; Cai, Mu-Yan; Li, Hai-Gang; Chen, Jie-Wei; Wang, Feng-Wei; Wang, Chen-Yuan; Hu, Wei-Wei; Liu, Fang; Xie, Dan Journal: Cancer letters Issue: Volume 539(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis. (20th November 2017) Authors: Bai, Hai-Yan; Liao, Yi-Ji; Cai, Mu-Yan; Ma, Ning-Fang; Zhang, Qi; Chen, Jie-Wei; Zhang, Jia-Xing; Wang, Feng-Wei; Wang, Chen-Yuan; Chen, Wen-Hui; Jin, Xiao-Han; Xu, Rui-Hua; Guan, Xin-Yuan; Xie, Dan Journal: Stem cells Issue: Volume 36:Number 2(2018) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1. Issue 48 (29th November 2018) Authors: Chen, Wen-Hui; Cai, Mu-Yan; Zhang, Jia-Xing; Wang, Feng-Wei; Tang, Lin-Quan; Liao, Yi-Ji; Jin, Xiao-Han; Wang, Chen-Yuan; Guo, Ling; Jiang, Yi-Guo; Ren, Cai-Ping; Mai, Hai-Qiang; Zeng, Mu-Sheng; Kung, Hsiang-Fu; Qian, Chao-Nan; Xie, Dan Journal: Oncogene Issue: Volume 37:Issue 48(2018) Page Start: 6243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Overexpression of SLC12A5 is associated with tumor progression and poor survival in ovarian carcinoma. Issue 8 (30th September 2019) Authors: Yang, Gui-Ping; He, Wei-Peng; Tan, Jin-Feng; Yang, Zun-Xian; Fan, Rong-Rong; Ma, Ning-Fang; Wang, Feng-Wei; Chen, Li; Li, Yang; Shen, Hong-Wei; You, Ze-Shan; Xie, Dan; Yang, Guo-Fen Journal: International journal of gynecological cancer Issue: Volume 29:Issue 8(2019) Page Start: 1280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma. Issue 1 (December 2016) Authors: Cai, Mu-Yan; Wang, Feng-Wei; Li, Chang-Peng; Yan, Li-Xu; Chen, Jie-Wei; Luo, Rong-Zhen; Yun, Jing-Ping; Zeng, Yi-Xin; Xie, Dan Journal: Chinese journal of cancer Issue: Volume 35:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗